Dong M Shin

14PUBLICATIONS
65CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 12, 2025
Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer.

Nicole C Schmitt, William A Stokes, James E Bates

|Apr 29, 2025
Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up.

Pauline Kim, Nabil F Saba, Ashley McCook-Veal

|Apr 14, 2025
Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163.

Nabil F Saba, Yael Flamand, Derrick T Lin

|Aug 21, 2024
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.

Nabil F Saba, Ritu Chaudhary, Kedar Kirtane

|Jul 09, 2024
Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives.

Sanghoon Han, Ramireddy Bommireddy, Pauline Kim

|May 02, 2024
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.

Saagar Pamulapati, Marin Abousaud, Yixuan Li

Pageof 3

Frequent Collaborators

12 joint publications

Nabil F Saba

6 joint publications

Mark W McDonald

4 joint publications

Mihir R Patel

3 joint publications

James E Bates